Background illustration for clinical trials search

Paid Clinical Trials Everett

Discover 1,443 paid clinical trials in Everett, Washington. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Validation of Consumer Activity Monitors in Postoperative Total Arthroplasty Patients

for
Arthropathy of Knee, Arthritis Knee, Arthritis, Degenerative
Location: Seattle WA
Sponsor: Benaroya Research Institute

Sex: All

Age: 18 - 70+

Code: NCT03958370

Recruiting

TAP Blocks vs. IV Lidocaine for Kidney Transplants

for
Postoperative Pain
Location: Seattle WA
Sponsor: Benaroya Research Institute

Sex: All

Age: 18+

Code: NCT03843879

Phase 2, Phase 3, Recruiting

Fabry Disease Registry & Pregnancy Sub-registry

for
Fabry Disease
Location: Seattle WA, Tacoma WA, Vancouver, Portland OR, Calgary,
Sponsor: Genzyme, a Sanofi Company

Sex: All

Age: 0+

Code: NCT00196742

Recruiting

Personalized Cancer Stem Cell High-Throughput Drug Screening for Glioblastoma

for
Newly Diagnosed Glioblastoma
Location: Seattle WA
Sponsor: Swedish Medical Center

Sex: All

Age: 18+

Code: NCT05380349

Early Phase 1, Recruiting

A Study to Investigate the Efficacy, Safety, Tolerability and Pharmacokinetics of PKN605 in Participants With Atrial Fibrillation

for
Atrial Fibrillation
Location: Seattle WA, Vancouver, Calgary, Murray UT, Tupelo MS,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07217067

Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Stereotactic Body Radiotherapy for Stage I-III Prostate Cancer

for
Prostate Cancer, Prostatic Cancer, Prostate Neoplasms,
Location: Seattle WA
Sponsor: Swedish Medical Center

Sex: All

Age: 18+

Code: NCT02334579

Recruiting

Medtronic Terminate AF Study

for
Persistent Atrial Fibrillation,
Location: Seattle WA, St Louis MO, Grand Rapids MI,
Sponsor: Medtronic Cardiac Surgery

Sex: All

Age: 18+

Code: NCT03546374

Recruiting

Safety and Immunogenicity of Recombinant DNA and Adenovirus Expressing L523S Protein in Early Stage Non-Small Cell Lung Cancer

for
Non-Small Cell Lung Cancer
Location: Seattle WA, Spokane WA, Dallas TX, Tyler TX, Ocoee FL
Sponsor: Corixa Corporation

Sex: All

Age: 18+

Code: NCT00062907

Phase 1, Recruiting

A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer

for
Carcinoma, Non-small-Cell Lung
Location: Seattle WA, Stanford CA, Orange CA, La Jolla CA,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT05498428

Phase 2, Recruiting

A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)

for
Breast Cancer
Location: Tacoma WA, Sacramento CA, Saskatoon, Regina,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06103864

Phase 3, Recruiting

A Trial Comparing Single Agent Melphalan to Carmustine, Etoposide, Cytarabine, and Melphalan (BEAM) as a Preparative Regimen for Patients With Multiple Myeloma Undergoing High Dose Therapy Followed by Autologous Stem Cell Reinfusion

for
Multiple Myeloma
Location: Seattle WA
Sponsor: Swedish Medical Center

Sex: All

Age: 18 - 70

Code: NCT03570983

Phase 2, Recruiting

Xcellerated T CellsTM for Non-Hodgkin's Lymphoma (NHL) Patients

for
Non-Hodgkin's Lymphoma
Location: Seattle WA, Portland OR, Greenbrae CA, San Francisco CA,
Sponsor: Xcyte Therapies

Sex: All

Age: 18+

Code: NCT00081783

Phase 2, Recruiting

Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancer

for
Ovarian Cancer, Fallopian Tube Cancer,
Location: Seattle WA, Portland OR, Los Angeles CA, La Jolla CA,
Sponsor: Regeneron Pharmaceuticals

Sex: Female

Age: 18+

Code: NCT06787612

Phase 2, Recruiting

A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma

for
Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma
Location: Seattle WA, Omaha NE, Rochester MN, Milwaukee WI,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT06876662

Recruiting

A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib

for
Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma
Location: Seattle WA, Omaha NE, Rochester MN, Milwaukee WI,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT06876649

Recruiting

A Randomized Phase 2 Trial of Fruquintinib and TAS-102 as Compared to Fruquintinib in Patients With Refractory Advanced/Metastatic Colorectal Cancer

for
Colorectal Cancer
Location: Seattle WA, San Antonio TX, Nashville TN, Pittsburgh PA,
Sponsor: Criterium, Inc.

Sex: All

Age: 18+

Code: NCT06992258

Phase 2, Recruiting

A Study of Intismeran Autogene (V940)/Placebo + Pembrolizumab and Chemotherapy in Metastatic Squamous Non-Small Cell Lung Cancer (V940-013)

for
Squamous Non-small Cell Lung Cancer
Location: Seattle WA, Corvallis OR, St Louis MO, Austin TX,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT07221474

Phase 2, Recruiting

BAFFR-targeting CAR T Cells for Patients With Relapsed or Refractory B-NHL

for
Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma
Location: Seattle WA, Stanford CA, Duarte CA, Minneapolis MN,
Sponsor: PeproMene Bio, Inc.

Sex: All

Age: 18+

Code: NCT05370430

Phase 1, Recruiting

A Registry Study of Breast Microseed Treatment

for
Breast Neoplasms
Location: Seattle WA, Pittsburgh PA, Fredericksburg VA
Sponsor: Concure Oncology-Breast Microseed Inc.

Sex: Female

Age: 50+

Code: NCT02701244

Recruiting

A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neoplasms

for
Neoplasms
Location: Seattle WA, Calgary, Duarte CA, Aurora CO, Goodyear AZ,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT06150157

Phase 1, Recruiting